CeriBell
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Visit website
LLY Eli Lilly and Company |
$1139.65 | -1.23% |
JNJ Johnson & Johnson |
$256.11 | -1.42% |
ABBV AbbVie |
$260.91 | 0.45% |
MRK Merck & Co. |
$143.38 | -0.27% |
UNH UnitedHealth Group Incorp… |
$368.09 | 0.81% |